Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026)
Genelux (GNLX) recorded quarterly Change in Acquisitions & Divestments of $6.8 million in Q1 2026, down 3.14% quarter-over-quarter from $7.0 million in Q4 2025, and up 13.0% on a YoY basis from $6.0 million in Q1 2025.
Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Genelux's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 13.0% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $32.3 million (up 25.36% YoY), while the FY2025 annual figure was $31.5 million, up 48.24% from the prior year.
- Change in Acquisitions & Divestments was $6.8 million for Q1 2026 at Genelux, down from $7.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $10.5 million in Q3 2025 to a low of $1.5 million in Q1 2024.
- Historically, Change in Acquisitions & Divestments has averaged $6.6 million across 3 years, with a median of $6.8 million in 2026.
- Biggest YoY gain for Change in Acquisitions & Divestments was 300.0% in 2025; the steepest drop was 3.45% in 2025.
- A 3-year view of Change in Acquisitions & Divestments shows it stood at $7.2 million in 2024, then dropped by 3.45% to $7.0 million in 2025, then slipped by 3.14% to $6.8 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |